Sunrest Lifescience Limited IPO is set to launch on 7 November, 2023. The company initiated its business operations in the year 2017. It is engaged in the business of personal care and healthcare products. The product portfolio includes tablets, Capsules, Syrups, Gel, Ointment, Solution, Mouthwash, Dry Powders, Suspension, Toothpaste etc. The drugs offered by the company are of extensive ranges like Antifungal, Antibacterial, Multimineral, Multivitamin, Anti-inflammatory, Nutraceutical, Cosmetic, AntiHistamine, Anti Protozoal, Dental Cure, Anti Parasitic etc. The company has 43 third party manufacturers for its drugs across states like Gujarat, Maharashtra, Punjab, Himachal Pradesh, Haryana, Madhya Pradesh, Uttarakhand etc. Sunrise Lifescience has a total of 32 products and 18 registered trademarks.
Sunrest Lifescience Limited IPO is set to launch on 7 November, 2023. The subscription timeline extends till 9 November, 2023. The size for the IPO is 10.85 Crore Rs. Shares issued through fresh issue mode are worth 10.85 Crore Rs. No shares are issued through offer for sale mode. The lot size is 1600 shares and the price is 84 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Fixed Price issue. The registrar for the company is Skyline Financial Services Limited.
IPO OPENING DATE | 7 November, 2023 |
CLOSING DATE FOR IPO | 9 November, 2023 |
ISSUE TYPE | Fixed Price Issue |
Face Value per share | 10 Rs. per share |
IPO price band | 84 Rs per share |
LOT SIZE | 1600 shares |
MINIMUM ORDER QUANTITY | 1600 shares |
ISSUE SIZE | 10.85 Crore Rs. |
OFFER FOR SALE | No shares are issued through offer for sale mode |
FRESH ISSUE | 10.85 Crore Rs. |
LISTING AT | NSE SME |
LISTING DATE | 20 November, 2023 |
IPO OPENING DATE | 7 November, 2023 |
CLOSING DATE FOR IPO | 9 November, 2023 |
IPO ALLOTMENT DATE | 15 November, 2023 |
REFUNDS | 16 November, 2023 |
DEMAT A/C CREDITED ON | 17 November, 2023 |
IPO LISTING DATE | 20 November, 2023 |
Sunrest Lifescience Limited IPO begins for subscription from 7 November, 2023. The IPO subscription would continue till 9 November, 2023. The allotment status for the shareholders who applied would come on 15 November, 2023. The refunds for the ones who did not get allotment would be initiated on 16 November, 2023. The DEMAT accounts of shareholders would be credited on 17 November, 2023. The listing of the company would be completed on 20 November, 2023.
The lead managers are :
The minimum lot size for the company is decided at 1600 shares. This holding accounts to 134400 Rs.. The maximum lot size is decided at 1600 shares (HNI). This amounts to 134400 Rs.. Hence the company’s final holdings would be set as :
Shares | Amount | |
Minimum | 1600 shares | 134400 Rs. |
Maximum | 1600 shares | 134400 Rs. |
Particularly (in Lakh Rs.) | 2020-21 | 2021-22 | 2022-23 |
ASSETS | 948 | 1301 | 1671 |
Revenue | 1649 | 2690 | 2467 |
PAT | 16 | 77 | 204 |
Sunrest Lifescience Limited had an asset base of 948 Lakh Rs in 2021 which increased to 1301 Lakh Rs in 2022 and 1671 Lakh Rs in 2023. The revenue of the firm was 1649 Lakh Rs in 2021 which increased to 2690 Lakh Rs in 2022. However in the year 2023 the revenue decreased to 2467 Lakh Rs. The profit of the firm was 16 Lakh Rs in the year 2021 which increased to 77 Lakh Rs in 2022. The profit of the firm was 204 Lakh Rs in the year 2023.
It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :
Now, applying for an IPO online is possible with most of the Discount and online brokers.
Effwa Infra & Research Limited IPO is set to launch on 5 July, 2024. The…
Ambey Laboratories Limited IPO is set to launch on 4 July, 2024. The company initiated…
Bansal Wire Industries Limited IPO is set to launch on 3 July, 2024. The company…
Emcure Pharmaceuticals Limited IPO is set to launch on 3 July, 2024. The company initiated…
Nephro Care India Limited IPO is set to launch on 28 June, 2024. The company…
Diensten Tech Limited IPO is set to launch on 26 June, 2024. The company initiated…
This website uses cookies.